Rapport Therapeutics, Inc. (RAPP) SEC Filings & Financial Intelligence
Rapport Therapeutics, Inc. (RAPP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RAPP
CIK: 2012593
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerFrancis Loftus
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-11-04 | 2026-09-30 | 10-Q | 0001193125-26-446217 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001193125-26-446202 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-10-30 | 4 | 0001193125-26-445438 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-28 | OWNERSHIP DOCUMENT | 0001104659-26-120789 | View SEC Doc Filr Page |
| 8-K | 2026-10-30 | 2026-10-28 | 8-K | 0001193125-26-441851 | View SEC Doc Filr Page |
| 424B5 | 2026-10-30 | — | 424B5 | 0001193125-26-439869 | View SEC Doc Filr Page |
| 424B5 | 2026-10-30 | — | 424B5 | 0001193125-26-439863 | View SEC Doc Filr Page |
| 305B2 | 2026-10-29 | — | 305B2 | 0001193125-26-437789 | View SEC Doc Filr Page |
| FWP | 2026-10-28 | — | FWP | 0001193125-26-435057 | View SEC Doc Filr Page |
| FWP | 2026-10-28 | — | FWP | 0001193125-26-435030 | View SEC Doc Filr Page |
| FWP | 2026-10-28 | — | FWP | 0001193125-26-434838 | View SEC Doc Filr Page |
| FWP | 2026-10-28 | — | FWP | 0001193125-26-434642 | View SEC Doc Filr Page |
| 424B5 | 2026-10-27 | — | 424B5 | 0001193125-26-434382 | View SEC Doc Filr Page |
| 424B5 | 2026-10-27 | — | 424B5 | 0001193125-26-434371 | View SEC Doc Filr Page |
| 4 | 2026-10-23 | 2026-10-21 | 4 | 0001193125-26-430504 | View SEC Doc Filr Page |
| 4 | 2026-10-23 | 2026-10-23 | 4 | 0001193125-26-430397 | View SEC Doc Filr Page |
| 4 | 2026-10-22 | 2026-10-22 | 4 | 0001193125-26-429075 | View SEC Doc Filr Page |
| 4 | 2026-10-22 | 2026-10-22 | 4 | 0001193125-26-429074 | View SEC Doc Filr Page |
| 4 | 2026-10-22 | 2026-10-22 | 4 | 0001193125-26-429073 | View SEC Doc Filr Page |
| 4 | 2026-10-22 | 2026-10-22 | 4 | 0001193125-26-429071 | View SEC Doc Filr Page |
| 4 | 2026-10-21 | 2026-10-21 | 4 | 0001193125-26-428018 | View SEC Doc Filr Page |
| 8-K | 2026-10-20 | 2026-10-20 | 8-K | 0001193125-26-425647 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-417919 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001958244-26-000649 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 | 0001193125-26-410734 | View SEC Doc Filr Page |